Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen 16:20:00 06/09/2024 BST 5-day change 1st Jan Change
881.50 DKK -0.42% Intraday chart for Novo Nordisk A/S -6.03% +26.27%
LockThis Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower MT
Novo Nordisk to present advances in diabetes treatment CF
Are thematic ETFs useless? Our Logo
Veeva Systems: leader in cloud solutions for the life sciences industry Our Logo
NOVO NORDISK : Gets a Neutral rating from Berenberg ZD
Health Care Declines as Risk Aversion Weighs - Health Care Roundup DJ
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading MT
NOVO NORDISK : JP Morgan remains its Buy rating ZD
How to find and check an Ozempic batch number RE
Ozempic shortages will hit some EU countries only - Novo Nordisk RE
Ozempic shortages in EU will not affect all member states - Novo Nordisk RE
US will still pay at least twice as much after negotiating drug prices RE
Novo Nordisk's Ozempic shortage expected to continue into Q4 RE
Biden Commends Eli Lilly for Cheaper Zepbound Version, Vows to Negotiate Lower Obesity Drug Prices MT
NOVO NORDISK : Deutsche Bank keeps its Buy rating ZD
Eli Lilly sells cheaper Zepbound option to meet demand RE
Lilly launches single-dose vials of Zepbound for weight loss to expand US supply RE
Analysis-Ozempic on Wall Street's list for 2027 Medicare drug negotiations RE
Health Care Ticks Up on Defensive Bias - Health Care Roundup DJ
Sector Update: Health Care Stocks Edge Up Late Afternoon MT
Sector Update: Health Care Stocks Rise Wednesday Afternoon MT
Global markets live: Novo Nordisk, Walmart, Target, Keysight Technologies, Coty... Our Logo
European Equities Traded in the US as American Depositary Receipts Trend Slightly Higher in Wednesday Trading MT
Sesame to Offer Novo Nordisk's Wegovy 'With No Retail Markup' MT
Sesame to Offer Customers Novo Nordisk's Wegovy at Lowered Price MT
Chart Novo Nordisk A/S
More charts
Logo Novo Nordisk A/S
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Employees
69,260
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
881.50DKK
Average target price
969.52DKK
Spread / Average Target
+9.99%
Consensus
  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. News Novo Nordisk A/S
  5. Novo Nordisk: Q2 miss; recent market fears should be capitalised on by long-term investors